Skip to main content

Advertisement

Log in

Auxotrophic recombinant Mycobacterium bovis BCG overexpressing Ag85B enhances cytotoxicity on superficial bladder cancer cells in vitro

  • Biotechnological products and process engineering
  • Published:
Applied Microbiology and Biotechnology Aims and scope Submit manuscript

Abstract

BCG therapy remains at the forefront of immunotherapy for treating patients with superficial bladder cancer. The high incidence of local side effects and the presence of non-responder diseases have led to efforts to improve the therapy. Hence, we proposed that an auxotrophic recombinant BCG strain overexpressing Ag85B (BCG ∆leuD/Ag85B), could enhance the cytotoxicity to the human bladder carcinoma cell line 5637. The rBCG was generated using an expression plasmid encoding the mycobacterial antigen Ag85B to transform a BCG ∆leuD strain. The inhibitory effect of BCG ∆leuD/Ag85B on 5637 cells was determined by the MTT method, morphology observation and a LIVE/DEAD assay. Gene expression profiles for apoptotic, cell cycle-related and oxidative stress-related genes were investigated by qRT-PCR. Bax, bcl-2 and p53 induction by BCG ∆leuD/Ag85B treatment was evaluated by Western blotting. BCG ∆leuD/Ag85B revealed a superior cytotoxicity effect compared to the control strains used in this study. The results showed that the expression level of pro-apoptotic and cell cycle-related genes increased after BCG ∆leuD/Ag85B treatment, whereas the mRNA levels of anti-apoptotic genes decreased. Interestingly, BCG ∆leuD/Ag85B also increased the mRNA level of antioxidant enzymes in the bladder cancer cell line. Bax and p53 proteins levels increased following treatment. In conclusion, these results suggest that treatment with BCG ∆leuD/Ag85B enhances cytotoxicity for superficial bladder cancer cells in vitro. Therefore, rBCG therapy may have potential benefits in the treatment of bladder cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Ali D, Ray RS, Hans RK (2010) UVA-induced cyototoxicity and DNA damaging potential of benz (e) acephenanthrylene. Toxicol Lett 199:193–200

    Article  CAS  Google Scholar 

  • Amirkhah R, Khanahmad H, Abolhassani M, Pooya M, Movassagh H, Shokrgozar MA (2009) Improvement of bladder cancer immunotherapy by creating a recombinant Bacille Calmette-Gu’erin which secrets p53 protein. Med Hypotheses 72:754

    Article  Google Scholar 

  • Andrade PM, Chade DC, Borra RC, Nascimento IP, Villanova FE, Leite LC, Andrade E, Srougi M (2010) The therapeutic potential of recombinant BCG expressing the antigen S1PT in the intravesical treatment of bladder cancer. Urol Oncol 28:520–525

    Article  CAS  Google Scholar 

  • Ariga H, Shimohakamada Y, Nakada M, Tokunaga T, Kikuchi T, Kariyone A, Tamura T, Takatsu K (2007) Instruction of naive CD4+ T-cell fate to T-bet expression and T helper 1 development: roles of T-cell receptor-mediated signals. Immunology 122:210–221

    Article  CAS  Google Scholar 

  • Borsuk S, Mendum TA, Fagundes MQ, Michelon M, Cunha CW, McFadden J, Dellagostin OA (2007) Auxotrophic complementation as a selectable marker for stable expression of foreign antigens in Mycobacterium bovis BCG. Tuberculosis (Edinb) 87:474–480

    Article  CAS  Google Scholar 

  • Campos VF, Collares T, Deschamps JC, Seixas FK, Dellagostin OA, Lanes CF, Sandrini J, Marins LF, Okamoto M, Sampaio LA, Robaldo RB (2010) Identification, tissue distribution and evaluation of brain neuropeptide Y gene expression in the Brazilian flounder Paralichthys orbignyanus. J Biosci 35:405–413

    Article  CAS  Google Scholar 

  • Cookson MS, Herr HW, Zhang ZF, Soloway S, Sogani PC, Fair WR (1997) The treated natural history of high risk superficial bladder cancer: 15-year outcome. J Urol 158:62–67

    Article  CAS  Google Scholar 

  • Denis O, Lozes E, Huygen K (1997) Induction of cytotoxic T-cell responses against culture filtrate antigens in Mycobacterium bovis bacillus Calmette-Guerin-infected mice. Infect Immun 65:676–684

    CAS  Google Scholar 

  • Ding GQ, Yu YL, Shen ZJ, Zhou XL, Chen SW, Liao GD, Zhang Y (2012) Antitumor effects of human interferon-alpha 2b secreted by recombinant bacillus Calmette-Guerin vaccine on bladder cancer cells. J Zhejiang Univ Sci B 13:335–341

    Article  CAS  Google Scholar 

  • Feng X, Zhang L, Zhu H (2009) Comparative anticancer and antioxidant activities of different ingredients of Ginkgo biloba extract (EGb 761). Planta Med 75:792–796

    Article  CAS  Google Scholar 

  • Gajewski TF, Thompson CB (1996) Apoptosis meets signal transduction: elimination of a BAD influence. Cell 87:589–592

    Article  CAS  Google Scholar 

  • Gamaley IA, Klyubin IV (1999) Roles of reactive oxygen species: signaling and regulation of cellular functions. Int Rev Cytol 188:203–255

    Article  CAS  Google Scholar 

  • Gochhait S, Dar S, Pal R, Gupta P, Bamezai RN (2009) Expression of DNA damage response genes indicate progressive breast tumors. Cancer Lett 273:305–311

    Article  CAS  Google Scholar 

  • Gontero P, Bohle A, Malmstrom PU, O’Donnell MA, Oderda M, Sylvester R, Witjes F (2010) The role of bacillus Calmette-Guerin in the treatment of non-muscle-invasive bladder cancer. Eur Urol 57:410–429

    Article  Google Scholar 

  • Gu D, Tonthat NK, Lee M, Ji H, Bhat KP, Hollingsworth F, Aldape KD, Schumacher MA, Zwaka TP, McCrea PD (2011) Caspase-3 cleavage links delta-catenin to the novel nuclear protein ZIFCAT. J Biol Chem 286:23178–23188

    Article  CAS  Google Scholar 

  • Hartwell LH, Weinert TA (1989) Checkpoints: controls that ensure the order of cell cycle events. Science 246:629–634

    Article  CAS  Google Scholar 

  • Hoft DF, Blazevic A, Abate G, Hanekom WA, Kaplan G, Soler JH, Weichold F, Geiter L, Sadoff JC, Horwitz MA (2008) A new recombinant bacille Calmette-Guerin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers. J Infect Dis 198:1491–1501

    Article  Google Scholar 

  • Hu L, Sun Y, Hu J (2010) Catalpol inhibits apoptosis in hydrogen peroxide-induced endothelium by activating the PI3K/Akt signaling pathway and modulating expression of Bcl-2 and Bax. Eur J Pharmacol 628:155–163

    Article  CAS  Google Scholar 

  • Huang TC, Huang HC, Chang CC, Chang HY, Ou CH, Hsu CH, Chen ST, Juan HF (2007) An apoptosis-related gene network induced by novel compound-cRGD in human breast cancer cells. FEBS Lett 581:3517–3522

    Article  CAS  Google Scholar 

  • Jagannath C, Lindsey DR, Dhandayuthapani S, Xu Y, Hunter RL Jr, Eissa NT (2009) Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells. Nat Med 15:267–276

    Article  CAS  Google Scholar 

  • Khan A, Tania M, Zhang D, Chen H (2010) Antioxidant enzymes and cancer. Chin J Cancer Res 22:87–92

    Article  CAS  Google Scholar 

  • Kim JM, Eckmann L, Savidge TC, Lowe DC, Witthoft T, Kagnoff MF (1998) Apoptosis of human intestinal epithelial cells after bacterial invasion. J Clin Invest 102:1815–1823

    Article  CAS  Google Scholar 

  • Kresowik TP, Griffith TS (2009) Bacillus Calmette-Guerin immunotherapy for urothelial carcinoma of the bladder. Immunotherapy 1:281–288

    Article  CAS  Google Scholar 

  • Kuo CJ, Bell H, Hsieh CL, Ptak CP, Chang YF (2012) Novel mycobacteria antigen 85 complex binding motif on fibronectin. J Biol Chem 287:1892–1902

    Article  CAS  Google Scholar 

  • Lee CF, Chang SY, Hsieh DS, Yu DS (2004) Treatment of bladder carcinomas using recombinant BCG DNA vaccines and electroporative gene immunotherapy. Cancer Gene Ther 11:194–207

    Article  CAS  Google Scholar 

  • Li LY, Luo X, Wang X (2001) Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 412:95–99

    Article  CAS  Google Scholar 

  • Lin CW, Su IJ, Chang JR, Chen YY, Lu JJ, Dou HY (2012) Recombinant BCG coexpressing Ag85B, CFP10, and interleukin-12 induces multifunctional Th1 and memory T cells in mice. APMIS 120:72–82

    Article  CAS  Google Scholar 

  • Liu J, Hinkhouse MM, Sun W, Weydert CJ, Ritchie JM, Oberley LW, Cullen JJ (2004) Redox regulation of pancreatic cancer cell growth: role of glutathione peroxidase in the suppression of the malignant phenotype. Hum Gene Ther 15:239–250

    Article  CAS  Google Scholar 

  • Ludwig AT, Moore JM, Luo Y, Chen X, Saltsgaver NA, O’Donnell MA, Griffith TS (2004) Tumor necrosis factor-related apoptosis-inducing ligand: a novel mechanism for Bacillus Calmette-Guerin-induced antitumor activity. Cancer Res 64:3386–3390

    Article  CAS  Google Scholar 

  • Luo Y, Yamada H, Chen X, Ryan AA, Evanoff DP, Triccas JA, O’Donnell MA (2004) Recombinant Mycobacterium bovis bacillus Calmette-Guerin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity. Clin Exp Immunol 137:24–34

    Article  CAS  Google Scholar 

  • Miramar MD, Costantini P, Ravagnan L, Saraiva LM, Haouzi D, Brothers G, Penninger JM, Peleato ML, Kroemer G, Susin SA (2001) NADH oxidase activity of mitochondrial apoptosis-inducing factor. J Biol Chem 276:16391–16398

    Article  CAS  Google Scholar 

  • Morales A, Eidinger D, Bruce AW (1976) Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol 116:180–183

    CAS  Google Scholar 

  • Mustafa AS, Amoudy HA, Wiker HG, Abal AT, Ravn P, Oftung F, Andersen P (1998) Comparison of antigen-specific T-cell responses of tuberculosis patients using complex or single antigens of Mycobacterium tuberculosis. Scand J Immunol 48:535–543

    Article  CAS  Google Scholar 

  • Naito M, Ohara N, Matsumoto S, Yamada T (1998) The novel fibronectin-binding motif and key residues of mycobacteria. J Biol Chem 273:2905–2909

    Article  CAS  Google Scholar 

  • Nepple KG, Aubert HA, Braasch MR, O’Donnell MA (2009) Combination of BCG and interferon intravesical immunotherapy: an update. World J Urol 27:343–346

    Article  CAS  Google Scholar 

  • O’Donnell MA (2009) Optimizing BCG therapy. Urol Oncol 27:325–328

    Article  Google Scholar 

  • Onumah OE, Jules GE, Zhao Y, Zhou L, Yang H, Guo Z (2009) Overexpression of catalase delays G0/G1- to S-phase transition during cell cycle progression in mouse aortic endothelial cells. Free Radic Biol Med 46:1658–1667

    Article  CAS  Google Scholar 

  • Pook SH, Esuvaranathan K, Mahendran R (2002) N-acetylcysteine augments the cellular redox changes and cytotoxic activity of internalized Mycobacterium bovis in human bladder cancer cells. J Urol 168:780–785

    Article  CAS  Google Scholar 

  • Roche PW, Triccas JA, Avery DT, Fifis T, Billman-Jacobe H, Britton WJ (1994) Differential T cell responses to mycobacteria-secreted proteins distinguish vaccination with bacille Calmette-Guerin from infection with Mycobacterium tuberculosis. J Infect Dis 170:1326–1330

    Article  CAS  Google Scholar 

  • Schwarzer K, Foerster M, Steiner T, Hermann IM, Straube E (2010) BCG strain S4-Jena: an early BCG strain is capable to reduce the proliferation of bladder cancer cells by induction of apoptosis. Cancer Cell Int 10:21

    Article  Google Scholar 

  • Siegel R, Ward E, Brawley O, Jemal A (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61:212–236

    Article  Google Scholar 

  • Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM, Kroemer G (1999) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397:441–446

    Article  CAS  Google Scholar 

  • Sylvester RJ, van der Meijden AP, Lamm DL (2002) Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol 168:1964–1970

    Article  CAS  Google Scholar 

  • Taylor WR, Stark GR (2001) Regulation of the G2/M transition by p53. Oncogene 20:1803–1815

    Article  CAS  Google Scholar 

  • Tsujimoto Y, Croce CM (1986) Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA 83:5214–5218

    Article  CAS  Google Scholar 

  • van LG, Schotte P, van GM, Demol H, Hoorelbeke B, Gevaert K, Rodriguez I, Ruiz-Carrillo A, Vandekerckhove J, Declercq W, Beyaert R, Vandenabeele P (2001) Endonuclease G: a mitochondrial protein released in apoptosis and involved in caspase-independent DNA degradation. Cell Death Differ 8:1136–1142

  • Vangestel C, Van De Wiele C, Mees G, Peeters M (2009) Forcing cancer cells to commit suicide. Cancer Biother Radiopharm 24:395–407

    Article  CAS  Google Scholar 

  • Wang J, Qie Y, Zhu B, Zhang H, Xu Y, Wang Q, Chen J, Liu W, Wang H (2009) Evaluation of a recombinant BCG expressing antigen Ag85B and PPE protein Rv3425 from DNA segment RD11 of Mycobacterium tuberculosis in C57BL/6 mice. Med Microbiol Immunol 198:5–11

    Article  CAS  Google Scholar 

  • Wang X (2001) The expanding role of mitochondria in apoptosis. Genes Dev 15:2922–2933

    CAS  Google Scholar 

  • Wiker HG, Harboe M (1992) The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol Rev 56:648–661

    CAS  Google Scholar 

  • Wu XZ, Wei HM, Zheng XD, Jin TC, Tian ZG (2007) Induction and mechanism study of anti-melanoma immune response by M. tuberculosis Ag85B. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 23:36–38

    CAS  Google Scholar 

  • Youle RJ, Strasser A (2008) The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9:47–59

    Article  CAS  Google Scholar 

  • Yu DS, Lee CF, Hsieh DS, Chang SY (2004) Antitumor effects of recombinant BCG and interleukin-12 DNA vaccines on xenografted murine bladder cancer. Urology 63:596–601

    Article  Google Scholar 

  • Yuksel ZS, Buber E, Kocagoz T, Alp A, Saribas Z, Acan NL (2011) Mycobacterial strains that stimulate the immune system most efficiently as candidates for the treatment of bladder cancer. J Mol Microbiol Biotechnol 20:24–28

    Article  CAS  Google Scholar 

  • Yun JM, Kweon MH, Kwon H, Hwang JK, Mukhtar H (2006) Induction of apoptosis and cell cycle arrest by a chalcone panduratin: a isolated from Kaempferia pandurata in androgen-independent human prostate cancer cells PC3 and DU145. Carcinogenesis 27:1454–1464

    Article  CAS  Google Scholar 

  • Zheng D, Wang Y, Zhang D, Liu Z, Duan C, Jia L, Wang F, Liu Y, Liu G, Hao L, Zhang Q (2011) In vitro antitumor activity of silybin nanosuspension in PC-3 cells. Cancer Lett 307:158–164

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by the Brazilian funding agencies: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and Fundação de Amparo à Pesquisa do Rio Grande do Sul (FAPERGS). The authors thank Alan McBride for a critical review of the manuscript.

Competing interests

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fabiana Kömmling Seixas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Begnini, K.R., Rizzi, C., Campos, V.F. et al. Auxotrophic recombinant Mycobacterium bovis BCG overexpressing Ag85B enhances cytotoxicity on superficial bladder cancer cells in vitro. Appl Microbiol Biotechnol 97, 1543–1552 (2013). https://doi.org/10.1007/s00253-012-4416-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00253-012-4416-2

Keywords

Navigation